Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-28 08:37 am Purchase | 2023-12-31 | 13G | Nuvectis Pharma, Inc. NVCT | Mosseri Marlio Charles | 2,595,000 15.000% | 214,824 (+9.03%) | Filing History |
| 2024-02-14 4:06 pm Purchase | 2023-12-31 | 13G | Beyond Air, Inc. XAIR | Mosseri Marlio Charles | 166,513 9.210% | 15,577 (+10.32%) | Filing History |
| 2023-02-14 4:10 pm Purchase | 2022-12-31 | 13G | Beyond Air, Inc. XAIR | Mosseri Marlio Charles | 150,935 9.990% | 35,304 (+30.53%) | Filing History |
| 2023-01-09 10:19 am Purchase | 2022-12-30 | 13G | Nuvectis Pharma, Inc. NVCT | Mosseri Marlio Charles | 2,380,176 16.300% | 977,620 (+69.70%) | Filing History |
| 2022-03-28 6:46 pm Purchase | 2022-03-22 | 13G | Nuvectis Pharma, Inc. NVCT | Mosseri Marlio Charles | 1,402,556 11.030% | 1,402,556 (New Position) | Filing History |
| 2022-02-15 5:18 pm Purchase | 2022-02-08 | 13G | Nuvectis Pharma, Inc. NVCT | Mosseri Marlio Charles | 1,265,200 9.950% | 1,265,200 (New Position) | Filing |
| 2022-02-08 5:35 pm Purchase | 2021-12-31 | 13G | Beyond Air, Inc. XAIR | Mosseri Marlio Charles | 115,631 7.760% | 16,653 (+16.83%) | Filing History |
| 2021-05-04 4:38 pm Purchase | 2021-04-30 | 13G | Beyond Air, Inc. XAIR | Mosseri Marlio Charles | 98,978 9.600% | 28,208 (+39.86%) | Filing History |